Loading resource…

Bruno Garcia and Matthieu Legrand
The commentary reflects on recent findings regarding the administration of vasopressors, particularly angiotensin II and vasopressin, in the context of distributive shock. It highlights the uncertainty surrounding optimal timing for initiation and the implications for patient outcomes. The document reviews existing literature and studies, including the ATHOS-3 trial, to evaluate the effectiveness of early vasopressor administration and its correlation with survival rates.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

VASOPRESSORS OR FLUIDS IN EARLY SEPTIC SHOCK
Same clinical topic · Critical Care Medicine

LOWER VS HIGHER FLUID VOLUMES IN ADULT PATIENTS WITH SEPSIS - AN UPDATED SYSTEMATIC REVIEW WITH META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS
Same clinical topic · Critical Care Medicine

INTERNATIONAL ANALGESIA AND SEDATION WEANING AND WITHDRAWAL PRACTICES IN CRITICALLY ILL ADULTS: THE ADULT IATROGENIC WITHDRAWAL STUDY IN THE ICU
Same clinical topic · Critical Care Medicine

HEPARIN-INDUCED THROMBOCYTOPAENIA
Same clinical topic · Critical Care Medicine

WHEN AND HOW MUCH? STEROIDS IN SEPSIS
Same clinical topic · Critical Care Medicine

THE ACID-BASE EFFECTS OF ALBUMIN IN SEPSIS: RECONCILING THE STEWART PHYSICOCHEMICAL APPROACH WITH THE TRADITIONAL BUFFER-BASE PARADIGM
Same clinical topic · Critical Care Medicine

Intubation in the Critically Ill: When, How, and How Long?
Same clinical topic · Critical Care Medicine

STATE - OF - THE - ART REVIEW: ß - BLOCKADE IN CRITICAL ILLNESS
Same clinical topic · Critical Care Medicine

STATE - OF - THE - ART REVIEW: ß - BLOCKADE IN CRITICAL ILLNESS
Same clinical topic · Critical Care Medicine